Lifecore Biomedical, Inc. Announces Commercial Launch of Corgel(TM) BioHydrogel
Published: May 11, 2009
CHASKA, Minn.--(BUSINESS WIRE)--LIFECORE BIOMEDICAL, LLC announced today the commercial launch of its proprietary Corgel™ BioHydrogel research kits. Corgel is a hyaluronan (hyaluronic acid) based biocompatible hydrogel. It was initially conceived and developed by scientists at Cleveland Clinic as a tissue bulking agent and drug delivery matrix. The tunability of the matrix and the biocompatibility also allows for the direct inclusion of cells or bioactive agents.